Company news
Therma Bright Inc. (TSXV:THRM) news
Therma Bright Inc. news releases on 6ix. Latest, Jul 30, 2026: Therma Bright Inc. Completes Debt Settlements
Press releases & updates
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
June 23, 2026
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
May 5, 2026
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
March 31, 2026
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
February 10, 2026
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
January 20, 2026
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
December 18, 2025
Therma Bright Appoints US Healthcare Veteran Michael Raimondo to the Board of Directors
October 10, 2025
Therma Bright Expands Relationship with Distribution Partner Gen-X Med for Venowave(TM) Sales
September 24, 2025
Therma Bright Proposes to Amend Certain Warrants
August 28, 2025
Therma Bright Announces Share Consolidation
July 3, 2025
Therma Bright Inc. Announces Share Consolidation
June 11, 2025
Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements
June 5, 2025
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
May 8, 2025
Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence
April 24, 2025
Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes
April 16, 2025
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
March 13, 2025
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
February 4, 2025
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
January 21, 2025
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
January 13, 2025
Therma Bright Announces Shares for Debt Issuance
January 9, 2025
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
December 18, 2024
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
December 11, 2024
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
December 5, 2024
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
November 18, 2024
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
October 28, 2024
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
October 10, 2024
Therma Bright Announces Non-Brokered LIFE Financing & Concurrent Private Placement for up to a combined CAD$6 Million
September 27, 2024
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
September 23, 2024
Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement
September 18, 2024
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
September 12, 2024
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
September 4, 2024
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
August 27, 2024
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
August 23, 2024
Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
August 22, 2024
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
August 19, 2024
Therma Bright's AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
August 16, 2024
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
August 13, 2024
Therma Bright Expands InStatin Investment
August 6, 2024
Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS)
August 1, 2024
Therma Bright's Venowave VW5 Secures FDA 510K Approval
July 29, 2024
Therma Bright Engages Independent Trading Group as Market Maker
July 18, 2024
Therma Bright Q2, 2024 Market Update On Business
July 3, 2024
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
June 21, 2024
Therma Bright Completes Debt Settlements
June 19, 2024
Therma Bright's Investment Case Just Got Stronger As Approval On Permanent Insurance Codes Gets Closer
June 12, 2024
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement
June 10, 2024
Therma Bright Announces up to $1,000,000 Unit Offering
May 22, 2024
Therma Bright Announces Strategic Review & Update on Investment in Inretio
March 21, 2024
Canadian Investment Regulatory Organization Trade Resumption - THRM
February 6, 2024